Advertisement

Abuse Potential of Mild Analgesics

  • Donald R. Jasinski
Part of the Advances in Behavioral Biology book series (ABBI, volume 6)

Abstract

It is generally held that drugs such as heroin and morphine, as well as other narcotic analgesics, share certain pharmacological properties which are indicative of their ability to produce dependence of the morphine type (1–4). These properties of morphine and morphine-like drugs are (a) the production of a characteristic set of subjective effects and euphoria, and (b) the production of physical dependence. The exact relationship and relative importance of these pharmacological properties to the initiation and maintenance of “addiction” are not clear since the pathophysiology of addiction is a matter of great debate.

Keywords

Subjective Effect Physical Dependence Abuse Potential Narcotic Analgesic Abrupt Withdrawal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  1. 1.
    Martin, W.R. and Fraser, H.F.: A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in postaddicts. J. Pharmacol. Exp. Ther. 133: 388–399, 1961.PubMedGoogle Scholar
  2. 2.
    Martin, W.R.: Assessment of the dependence producing potentiality of narcotic analgesics. In Radouco-Thomas, C. and Lasagna, L. (Eds.): International Encyclopedia of Pharmacology and Therapeutics, pp. 155–180, Ch. 9, Sec. 6, Vol. I, Pergamon Press, Glasgow, 1966.Google Scholar
  3. 3.
    World Health Organization: Evaluation of dependence-producing drugs. Report of a WHO Scientific Group. Wld. Hlth Org. Techn. Rep. Ser. 287, 1964.Google Scholar
  4. 4.
    Fraser, H.F., Van Horn, G.D., Martin, W.R., Wolbach, A.B., and Isbell, H.: Methods for evaluating addiction liability (A) “Attitude” of opiate addicts toward opiate-like drugs, (B) A short-term “direct” addiction test. J. Pharmacol. Exp. Ther. 133: 371–387, 1961.PubMedGoogle Scholar
  5. 5.
    Fraser, H.F. and Isbell, H.: Pharmacology and addiction liability of dl-and d-propoxyphene. Bull. Narcotics 12: 9–14, 1960.Google Scholar
  6. 6.
    Fraser, H.F., Martin, W.R., Wolbach, A.B. and Isbell, H.: Addiction liability of an isoquinoline analgesic, 1-(p-chloro-phenethyl-2-methyl-6,7-dimethoxy1,2,3,4-tetrahydroisoquinoline.) Clin. Pharmacol. Ther. 2: 287–299, 1961.Google Scholar
  7. 7.
    Jasinski, D.R., Martin, W.R. and Hoeldtke, R.: Studies of the dependence-producing properties of GPA-1657, profadol, and propiram in man. Clin. Pharmacol. Ther. 12: 613–649, July-Aug. 1971.Google Scholar
  8. 8.
    Fraser, H.F. and Isbell, H.: Human pharamacology and addictiveness of ethyl-1-(3-cyano-3,3-phenylpropyl)-4-phenyl-4-piperidine carboxylate hydrochloride (R-1132, Diphenoxylate). Bull. Narcotics 13: 29–43, Jan-Mar. 1961.Google Scholar
  9. 9.
    Lasagna, L. and Beecher, H.K.: The analgesic effectiveness of nalorphine and nalorphine-morphine combinations in man. J. Pharmacol. Exp. Ther. 112: 356–363, 1964.Google Scholar
  10. 10.
    Martin, W.R., Fraser, H.F., Gorodetzky, C.W. and Rosenberg, D.E.: Studies of the dependence-producing potential of the narcotic antagonist 2-cyclo-propylmethyl-2’-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, Win 20,740,ARC II-C-3). J. Pharmacol. Exp. Ther. 150: 426–436, 1965.PubMedGoogle Scholar
  11. 11.
    Martin, W.R. and Gorodetzky, C.W.: Demonstration of tolerance to and physical dependence on N-allylnormorphine (nalorphine). J. Pharmacol. Exp. Ther. 150: 437–442, 1965.PubMedGoogle Scholar
  12. 12.
    Fraser, H.F. and Rosenberg, D.E.: Studies on the human addiction liability of 2’-hydroxy-5,9- dime thyl-2(3,3-dimethylallyl)-6,7-benzomorphan (Win 20,228); a weak narcotic antagonist. J. Pharmacol. Exp. Ther. 143: 149–156, 1964.PubMedGoogle Scholar
  13. 13.
    Jasinski, D.R., Martin, W.R. and Hoeldtke, R.D.: Effects of short-and long-term administration of pentazocine in man. Clin. Pharmacol. Ther. 11: 385–403, May-June 1970.Google Scholar

Copyright information

© Plenum Press, New York 1973

Authors and Affiliations

  • Donald R. Jasinski

There are no affiliations available

Personalised recommendations